Convalescent Plasma News and Research

RSS
Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

South African and Brazilian SARS-CoV-2 variants can evade antibodies from therapies, vaccines, and infection

South African and Brazilian SARS-CoV-2 variants can evade antibodies from therapies, vaccines, and infection

70% of SARS-CoV-2 infected in Wuhan still have IgG antibodies

70% of SARS-CoV-2 infected in Wuhan still have IgG antibodies

Study finds CD8+ T cell responses detect all major SARS-CoV-2 variants

Study finds CD8+ T cell responses detect all major SARS-CoV-2 variants

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

Have scientists found SARS-CoV-2's Achilles' heel?

Have scientists found SARS-CoV-2's Achilles' heel?

Scientists seek Covid treatment answers in cheap, older drugs

Scientists seek Covid treatment answers in cheap, older drugs

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

Detecting SARS-CoV-2 specific IgG antibodies with the Kantaro Covid-SeroKlir Kit

Detecting SARS-CoV-2 specific IgG antibodies with the Kantaro Covid-SeroKlir Kit

Study suggests SARS-CoV-2 antibodies in breast milk are robust, neutralizing and durable

Study suggests SARS-CoV-2 antibodies in breast milk are robust, neutralizing and durable

A green tea compound shows anti-SARS-CoV-2 properties in vitro

A green tea compound shows anti-SARS-CoV-2 properties in vitro

Prediction of antibody responses in recovered COVID-19 patients remains unclear

Prediction of antibody responses in recovered COVID-19 patients remains unclear

The hype has faded, but don’t count out convalescent plasma in Covid battle

The hype has faded, but don’t count out convalescent plasma in Covid battle

Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation

Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation

SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion

SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion

How resistant is the SARS-CoV-2 Brazilian variant to antibodies?

How resistant is the SARS-CoV-2 Brazilian variant to antibodies?

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

Why does convalescent plasma therapy for severe COVID-19 show mixed success?

Why does convalescent plasma therapy for severe COVID-19 show mixed success?